Criteria Used for Priority-Setting for Public Health Resource Allocation in Low- and Middle-Income Countries: A Systematic Review.

Criteria Health policy Priority setting Resource allocation Systematic review

Journal

International journal of technology assessment in health care
ISSN: 1471-6348
Titre abrégé: Int J Technol Assess Health Care
Pays: England
ID NLM: 8508113

Informations de publication

Date de publication:
2019
Historique:
pubmed: 17 7 2019
medline: 7 8 2020
entrez: 17 7 2019
Statut: ppublish

Résumé

This systematic review aimed to identify criteria being used for priority setting for resource allocation decisions in low- and middle-income countries (LMICs). Furthermore, the included studies were analyzed from a policy perspective to understand priority setting processes in these countries. Searches were carried out in PubMed, Embase, Econlit, and Cochrane databases, supplemented with pre-identified Web sites and bibliographic searches of relevant papers. Quality appraisal of included studies was undertaken. The review protocol is registered in International Prospective Register of Systematic Reviews PROSPERO CRD42017068371. Of 16,412 records screened by title and abstract, 112 papers were identified for full text screening and 44 studies were included in the final analysis. At an overall level, cost-effectiveness 52 percent (n = 22) and health benefits 45 percent (n = 19) were the most cited criteria used for priority setting for public health resource allocation. Inter-region (LMICs) and between various approaches (like health technology assessment, multi-criteria decision analysis (MCDA), accountability for reasonableness (AFR) variations among criteria were also noted. Our review found that MCDA approach was more frequently used in upper middle-income countries and AFR in lower-income countries for priority setting in health. Policy makers were the most frequently consulted stakeholders in all regions. Priority-setting criteria for health resource allocation decisions in LMICs largely comprised of cost-effectiveness and health benefits criteria at overall level. Other criteria like legal and regulatory framework conducive for implementation, fairness/ethics, and political considerations were infrequently reported and should be considered.

Identifiants

pubmed: 31307561
pii: S0266462319000473
doi: 10.1017/S0266462319000473
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

474-483

Auteurs

Gunjeet Kaur (G)

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research.

Shankar Prinja (S)

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research.

P V M Lakshmi (PVM)

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research.

Laura Downey (L)

Centre for Global Health and Development, Imperial College.

Deepshikha Sharma (D)

Department of Community Medicine and School of Public Health, Post Graduate Institute of Medical Education and Research.

Yot Teerawattananon (Y)

Health Intervention and Technology Assessment Program (HITAP); Saw Swee Hock School of Public Health, National University of Singapore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH